Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 28,160 shares at $53.54 ($1.5M) on 2026-03-30, disclosed to the SEC on 2026-03-31.
Scheduled sale ($1.5M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.54 | 6,423 | $344K | 22.7% |
| 2 | $53.54 | 6,423 | $344K | 22.7% |
| 3 | $54.31 | 617 | $34K | 2.2% |
| 4 | $54.31 | 617 | $34K | 2.2% |
| 5 | $53.87 | 6,609 | $356K | 23.5% |
| 6 | $53.87 | 6,609 |
| $356K |
| 23.5% |
| 7 | $54.35 | 431 | $23K | 1.5% |
| 8 | $54.35 | 431 | $23K | 1.5% |
| Total | $53.75 avg | 28,160 | $1.5M | 100% |
| Filing → |
| PAHC | SELL | 2026-04-23 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-26 | $2.3M | — | Filing → |